Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Obejuan who wrote (904)	5/6/1998 10:06:00 AM
From: Jim Reome	Read Replies (1) \| Respond to of 1476

Company has given credibility with Phase II announcement. Many were wondering if they would hold until after meeting in June. Very positive sign and can not ask for better news to be announced to get stockholders on positive side of the reverse. I have went with the reverse approval based on yesterdays announcement.

To: Obejuan who wrote (904)	5/6/1998 5:59:00 PM
From: Amigo Mike	Read Replies (1) \| Respond to of 1476

Obejuan, I am voting for the reverse. I want a listing. Otherwise Antex will continue to languish in obscurity. To give you an example...... Antex was called by a major business news channel a few months ago when Campy was big in the news. Dr Esposito was asked if he could get to a TV studio within an hour or so for an interview ... which he immediately accepted. While he was hurrying to prepare for the interview and rush to the studio ...... the news channel called back and cancelled the interview. Upon questioning ...... Antex was denied the interview because they are a BB stock. And that was the ONLY reason. Dr Esposito talked to them a bit .... trying to reinstate the interview ... but was denied simply because Antex was not a listed stock. They LOVED Antex and WANTED the interview ...... BUT when they checked into the company ....... oh well. I do believe this story is a big reason why the company has requested permission from shareholders for a reverse split if necessary for listing. I have been for the reverse for a year and a half. Hopefully Antex will achieve $4 on it's own. A little news about starting Phase III Campy and some information from the company regarding H Pylori as a preventative for stomach cancer and Antex could make it. We will see. H Pylori results due 3rd qtr. Mike